Abstract
Researchers and engineers came together in Lisbon at the 27
th Meeting of the European Society for Animal Cell
Technology (ESACT 2022), to discuss the latest advances in technologies
associated with protein-based biologics production, new modalities and
cell, gene and tissue therapies. Main contributions focused on how the
capabilities of production platforms can be enhanced, and how to
leverage them to generate new products. Some of the advances that were
presented are discussed below, including those related with cell line
development, metabolic engineering, analytics, CHO and insect cells
platforms engineering, vesicle and viral vector production, and gene and
cell therapy, along with some concluding remarks on the future of this
important field.